BIOMAT Database Logo BIOMAT Database Logo

Antigenic structure of human respiratory syncytial virus fusion glycoprotein. 1998

J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Centro Nacional de Biología Fundamental, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.

New series of escape mutants of human respiratory syncytial virus were prepared with monoclonal antibodies specific for the fusion (F) protein. Sequence changes selected in the escape mutants identified two new antigenic sites (V and VI) recognized by neutralizing antibodies and a group-specific site (I) in the F1 chain of the F molecule. The new epitopes, and previously identified antigenic sites, were incorporated into a refined prediction of secondary-structure motifs to generate a detailed antigenic map of the F glycoprotein.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral

Related Publications

J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Antigenic structure of the fusion glycoprotein of respiratory syncytial virus.
January 1989, Advances in experimental medicine and biology,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Purification of human respiratory syncytial virus fusion glycoprotein.
January 2012, Protein expression and purification,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.
November 2013, Science (New York, N.Y.),
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
December 1993, The Journal of general virology,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F.
December 2010, Journal of virology,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virus.
June 1989, The Journal of biological chemistry,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
January 2016, PloS one,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
October 1997, The Journal of general virology,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.
April 2015, Current opinion in virology,
J A López, and R Bustos, and C Orvell, and M Berois, and J Arbiza, and B García-Barreno, and J A Melero
Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
September 1992, The Journal of general virology,
Copied contents to your clipboard!